Germany
Japan
United Kingdom
China
Lenti-ORF Control Particles
Lenti ORF control particles of pLenti-C-mGFP-P2A-Puro, >1x10^7 TU/ml, 0.5 ml
Product Datasheet for 'PS100093V'
USD 310.00
Availability*
In Stock
Size
Product images
Specifications
| Product Data | |
| Description | Lenti ORF control particles of pLenti-C-mGFP-P2A-Puro, >1x10^7 TU/ml, 0.5 ml |
| Fluorescent Label | None |
Citations (3)
| The use of this Others has been cited in the following citations: |
|---|
|
Breast cancer-associated skeletal muscle mitochondrial dysfunction and lipid accumulation is reversed by PPARG
,Wilson, HE;Stanton, DA;Pistilli, EE;,
BioRxiv 2020
[Negative Control]
|
|
Rational cotargeting of HDAC6 and BET proteins yields synergistic antimyeloma activity
,Carew, JS;Espitia, CM;Zhao, W;Visconte, V;Anwer, F;Kelly, KR;Nawrocki, ST;,
Blood Adv 2019
,PubMed ID 31015208
[Negative Control]
|
|
Differential expression of secreted factors SOSTDC1 and ADAMTS8 cause pro-fibrotic changes in linear morphoea fibroblasts
,Badshah, II;Brown, S;Weibel, L;Rose, A;Way, B;Sebire, N;Inman, G;Harper, J;Kinsler, V;O'Shaughnessy, R;,
Br. J. Dermatol. 2018
,PubMed ID 30367460
[Negative Control]
|
Documents
Customer
Reviews
Loading...
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen
complexities in the preparation of your product. International customers may expect an additional 1-2 weeks
in shipping.
